Additionally, miR-495-3p targets GRP78 and regulates mammalian target of rapamycin (mTOR) to modulate autophagy in MDR cells, thereby sensitizing gastric cancer cells to chemotherapy (Chen et al., 2018). The gene discussed is MTOR; the disease is gastric cancer.